Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Choroidal Response to Novel Spectacle Lens to Control Myopia Progression

NCT: NCT03818880 · ACTIVE_NOT_RECRUITING

NCT IDNCT03818880
StatusACTIVE_NOT_RECRUITING
Start Date2018-12-18
Completion2026-12-31

Brief Summary

Diurnal variations in the thickness of the choroid have been reported in the literature, and, more recently, the role of the choroid has been studied with respect to its role in myopia (near-sightedness) progression.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑